Related Experiment Videos
Publisher Correction: Phage therapy's latest makeover.
1, Portland, Maine, USA.
Nature Biotechnology
|May 23, 2019
Summary
This article corrects previous inaccuracies regarding companies involved in phage therapy development. It updates the active company list and clarifies company locations for better accuracy in the field of phage therapeutics.
Area of Science:
- Biotechnology
- Microbial Therapeutics
- Pharmaceutical Development
Background:
- Phage therapy, using bacteriophages to combat bacterial infections, has seen renewed interest.
- A decade ago, numerous companies were exploring phage-based treatments.
- Accurate tracking of active companies is crucial for understanding the field's progress.
Purpose of the Study:
- To correct factual errors in a previously published article concerning companies in the phage therapy sector.
- To ensure the accuracy of company listings and their operational status.
- To provide a precise overview of the current landscape of phage therapy development.
Main Methods:
- Review and verification of company information.
- Correction of specific details regarding company activity and location.
- Updating the article's HTML and PDF versions with accurate data.
Main Results:
- Phico Therapeutics was incorrectly omitted from the list of active phage therapy companies.
- PhageTech's location has been clarified as Canada.
- Minor textual corrections were made for temporal accuracy.
Conclusions:
- The updated article provides a more accurate representation of companies engaged in phage therapy.
- Corrected information enhances the reliability of data on phage therapeutic development.
- Ensuring accuracy is vital for researchers and stakeholders in the emerging field of phage treatments.